ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,636.00
-15.00 (-0.91%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -15.00 -0.91% 1,636.00 1,638.00 1,639.00 1,661.50 1,635.50 1,656.50 4,329,161 16:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.69 67.46B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,651p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.46 billion. Gsk has a price to earnings ratio (PE ratio) of 13.69.

Gsk Share Discussion Threads

Showing 13126 to 13148 of 33100 messages
Chat Pages: Latest  532  531  530  529  528  527  526  525  524  523  522  521  Older
DateSubjectAuthorDiscuss
25/8/2016
09:41
Clinton joined senators Susan Collins and Claire McCaskill in highlighting US-based Mylan's 480% hike in the price of its EpiPen epinephrine product since the company acquired it in 2007.Sending signals about the potential direction of drug policy if she wins the presidential race, Clinton called on Mylan to drop the price of EpiPen, which has leapt from $100 for a two-pack in 2007 to around $600 today."That's outrageous - and it's just the latest troubling example of a company taking advantage of its consumers," Clinton said in a statement."It's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."Senators Collins and McCaskill have called for an "urgent briefing" with Mylan's chief executive officer Heather Bresch following a public clamour for a government reaction to the pharma industry's freewheeling price increases.The senators noted that Mylan's "profitability appears to have skyrocketed" during the period, raising concerns that the price increases "were not driven by increased costs of production or product improvements".Mylan said in a statement that ensuring access to epinephrine is "a core part of our mission" and highlighted that 80% of commercially insured patients on their assistance program received the product at no cost in 2015.Not long before 0930 on Thursday, Hikma was down 4.71% to 2,123p, Shire was 4.1% lower at 4,819p, AstraZeneca by 2.5% to 4,954p and GlaxoSmithKline sliding 1.6% to 1,632.5p.
mj19
25/8/2016
09:35
And rightly so Dr from what I have read.

Buying in to buoyant sentiment in the stock market is usually
a quick way to the poorhouse, give me some caution any day.

essentialinvestor
25/8/2016
09:27
Looking to buy in for the dividend....would appreciate any chartists view with any thoughts on a good entry price

I find that odd. Charting is nonsense in my view, but even forgetting that, why would a dividend player consider charts which are about predicting price action and have nothing to do with dividend or yield?

I'm an income investor, that's the only reason I invest in shares at all and specifically high yielders. To me, it follows that if using shares for income the timing device of when to get in and out ought to be directly related to the reason you want to invest. That means logically some dividend/yield related method. So if the yield is high, then it's buying time and vice versa.

There are various ways you could do it, I use the yield relative to the FTSE100. GSK which I've held for years still yields well above that so is a buy at any price in my approach, assuming the underlying fundamentals remain attractive, until its yield is no longer much above the then index. If I was looking to buy it now, what would price action or charts matter?

anhar
25/8/2016
09:22
Clinton going after mylan last night won't help sentiment.
dr biotech
25/8/2016
08:27
Added a few on the dip.
essentialinvestor
24/8/2016
19:02
warranty Also agree with what you say a good entry point and being a long term holder and just collect the dividends.....Thanks also for your advice.
spcecks
24/8/2016
18:56
The bubble looks in bonds ATM, not equities.

Equities can correct at any point and by most historical
measures we are late in this bull market.

Expected a minor give back of 3-4% in August which has not happened.

Overall trend looks higher for Autumn, just a best guess.

essentialinvestor
24/8/2016
18:55
bracke Agree with your post on savers driving certain share prices higher so looking for a good entry point.....Thanks again good sound advice.
spcecks
24/8/2016
18:26
Spot on bracke and it will probably happen before too long. That's when having a good entry point and holding for the dividend is at it's most valuable. If you're comfortable just collecting that dividend then the day to day share price movements are largely irrelevant. As you say, it's never nice to see your SP's drop but if you're a long termer you'd know it's all part of the rich tapestry of investing.
warranty
24/8/2016
13:40
spcecks

Yes the low interest rates are driving savers into shares and other assets which obviously drives up the prices. The problem comes when the buying pressure slows or ceases and prices start to drop. That's when it can be unpleasant especially for those who have little knowledge of the market.

bracke
24/8/2016
13:31
Thanks bracke much appreciated will wait to see what happens on Friday....So fed up with the low interest rates on saving accounts ......have decided to buy some quality dividend stocks any ideas appreciated.
spcecks
24/8/2016
12:35
The probability is that the share price will test support at 1625 (magenta line). This may be influenced by what occurs at Jackson Hole on Friday.
bracke
24/8/2016
12:14
Looking to buy in for the dividend....would appreciate any chartists view with any thoughts on a good entry price.
spcecks
24/8/2016
11:55
Quite relieved that I took my money off the table at 1700.
salpara111
24/8/2016
09:27
SOLD: 12,341 shares @1655p .... ;0)
tradermichael
17/8/2016
17:44
Dividends are not an illusion but in some cases perhaps their sustainability is. Dividends at the expense of pension contributions is another thing to be aware of.
greenpastures2
17/8/2016
11:57
Agreed with investment "illusions". That's one reason I focus on divs. They are not an illusion but an actual cash payment.

The share price and its wandering random movement is an illusion, at least until one of my rare sells then it becomes the reality of cash. But is quickly turned back into an illusion when I reinvest it into a new HY share.

Charts, hundreds of different opinions on bulletin boards, those are illusions where you see what you want to see, hear what you want to hear, wholly subjective reactions influenced by classic small investor psych. weaknesses like confirmation bias and recent events bias.

anhar
17/8/2016
11:28
Indeed - in fact you could argue that "MUCH" is a £1.57 trillion illusion!
fangorn2
17/8/2016
08:59
That is the danger with many of the commentaries and many of the posts around the place - much is an illusion.
alphorn
17/8/2016
07:47
ADRs were $43 in May and are now about $44...in USD terms the price hasn't changed
dr biotech
16/8/2016
23:56
A picture paints ....
tim 3
16/8/2016
22:27
Richard - just look at how much GBP has fallen!!!
alphorn
16/8/2016
18:39
Good points thanks. Seems quite an excessive jump purely based on currency benefits but I'm a poor PI and know nothing ! May top slice this week and look to buyback 'if' it drops
richard98765
Chat Pages: Latest  532  531  530  529  528  527  526  525  524  523  522  521  Older

Your Recent History

Delayed Upgrade Clock